Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.06 USD
Change Today +0.0049 / 8.17%
Volume 55.1K
As of 5:20 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

vg life sciences inc (VGLS) Snapshot

Open
$0.05
Previous Close
$0.06
Day High
$0.07
Day Low
$0.05
52 Week High
07/1/14 - $0.19
52 Week Low
12/15/14 - $0.04
Market Cap
4.1M
Average Volume 10 Days
69.3K
EPS TTM
$-18.00
Shares Outstanding
63.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VG LIFE SCIENCES INC (VGLS)

Related News

No related news articles were found.

vg life sciences inc (VGLS) Related Businessweek News

No Related Businessweek News Found

vg life sciences inc (VGLS) Details

VG Life Sciences, Inc., a drug discovery and development company, engages in the research and development of therapeutic and diagnostic pharmaceutical and medical products in the United States. The company is involved in the research and development of drugs and disease treatments using two platform technologies, Targeted Peptide Technology (TPT) and Metabolic Disruption Technology (MDT). Its product candidates include VG1177, an anti-inflammatory peptide that is in pre-clinical stage for the treatment of HIV/AIDS; and Hydroxychloroquine, a MDT compound, which is in clinical-stage for treating drug resistant cancer. The company was formerly known as Viral Genetics, Inc. and changed its name to VG Life Sciences, Inc. in November 2012. VG Life Sciences, Inc. was founded in 1995 and is based in Santa Barbara, California.

1 Employees
Last Reported Date: 04/15/15
Founded in 1995

vg life sciences inc (VGLS) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Co-Founder, Chairman, Vice President of Resea...
Total Annual Compensation: $292.5K
Chief Financial Officer and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

vg life sciences inc (VGLS) Key Developments

VG Life Sciences Inc. announced delayed 10-Q filing

On 05/15/2015, VG Life Sciences Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

VG Life Sciences Inc. Auditor Raises 'Going Concern' Doubt

VG Life Sciences Inc. filed its 10-K on Apr 15, 2015 for the period ending Dec 31, 2014. In this report its auditor, Killman, Murrell & Company, P.C. - KWCO PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

VG Life Sciences Inc. announced delayed annual 10-K filing

On 03/31/2015, VG Life Sciences Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VGLS:US $0.06 USD +0.0049

VGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VGLS.
View Industry Companies
 

Industry Analysis

VGLS

Industry Average

Valuation VGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VG LIFE SCIENCES INC, please visit www.viralgenetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.